Mitsubishi Tanabe Pharma buys Neuroderm for $1.1 billion
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
All company news and stories
Japanese pharmaceutical giant to acquire Israel’s Neuroderm in record breaking deal
The BIRAX program brings together world-leading scientists to advance breakthroughs in regenerative medicine
Professor Lloyd B. Minor M.D., dean of Stanford University School of Medicine, one of the best medical schools in the world, recently visited Rambam HCC to learn more about what goes on in the largest hospital in Northern Israel.
Israeli startup offers revolutionary way to monitor heartbeat, blood pressure, respiration rate, lung sounds, muscle activity and blood glucose.
Developed in Israel, the Nanose device analyzes breath in order to detect diseases such as cancer and Parkinson’s, even in their earliest stages.
Cancer is the second-leading cause of death in the United States, responsible for 22.5 percent of American fatalities. Only heart disease is more deadly. In Israel, cancer is the No. 1 killer. That’s partly why Israel has become a research leader in the fight against the disease. Many of the world’s most effective cancer treatments have roots in Israeli research, sometimes going back decades. The work taking place in Israeli labs today may lead to lifesaving treatments years in the future.
FasTouch gives surgeons a new tool for attaching mesh to tissue, leading to fewer complications, less pain and faster recovery from hernia procedures.
A digital health company from the UK wants to change the way a patient interacts with a doctor through the creation of an artificial intelligence (AI) doctor in the form of an AI chatbot.
The demand for disposable medical supplies will rise over the next four years.